375 related articles for article (PubMed ID: 1868460)
1. Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl.
Kadlubar FF; Dooley KL; Teitel CH; Roberts DW; Benson RW; Butler MA; Bailey JR; Young JF; Skipper PW; Tannenbaum SR
Cancer Res; 1991 Aug; 51(16):4371-7. PubMed ID: 1868460
[TBL] [Abstract][Full Text] [Related]
2. Identification of N-(deoxyguanosin-8-yl)-4-azobiphenyl by (32)P-postlabeling analyses of DNA in human uroepithelial cells exposed to proximate metabolites of the environmental carcinogen 4-aminobiphenyl.
Hatcher JF; Swaminathan S
Environ Mol Mutagen; 2002; 39(4):314-22. PubMed ID: 12112383
[TBL] [Abstract][Full Text] [Related]
3. A pharmacokinetic model to predict exposure of the bladder epithelium to urinary N-hydroxyarylamine carcinogens as a function of urine pH, voiding interval, and resorption.
Young JF; Kadlubar FF
Drug Metab Dispos; 1982; 10(6):641-4. PubMed ID: 6130914
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and nucleic acid binding of N-hydroxy-4-acetylaminobiphenyl and N-acetoxy-4-acetylaminobiphenyl by cultured human uroepithelial cells.
Swaminathan S; Reznikoff CA
Cancer Res; 1992 Jun; 52(12):3286-94. PubMed ID: 1375866
[TBL] [Abstract][Full Text] [Related]
5. Immunochemical quantitation of DNA adducts derived from the human bladder carcinogen 4-aminobiphenyl.
Roberts DW; Benson RW; Groopman JD; Flammang TJ; Nagle WA; Moss AJ; Kadlubar FF
Cancer Res; 1988 Nov; 48(22):6336-42. PubMed ID: 3180051
[TBL] [Abstract][Full Text] [Related]
6. Chronic, topical administration of 4-aminobiphenyl induces tissue-specific DNA adducts in mice.
Underwood PM; Zhou Q; Jaeger M; Reilman R; Pinney S; Warshawsky D; Talaska G
Toxicol Appl Pharmacol; 1997 Jun; 144(2):325-31. PubMed ID: 9194416
[TBL] [Abstract][Full Text] [Related]
7. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
8. Microsome-mediated transacetylation and binding of N-hydroxy-4-aminobiphenyl to nucleic acids by hepatic and bladder tissues from dog.
Hatcher JF; Swaminathan S
Carcinogenesis; 1992 Oct; 13(10):1705-11. PubMed ID: 1423829
[TBL] [Abstract][Full Text] [Related]
9. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.
Sarkar M; Stabbert R; Kinser RD; Oey J; Rustemeier K; von Holt K; Schepers G; Walk RA; Roethig HJ
Toxicol Appl Pharmacol; 2006 Jun; 213(3):198-206. PubMed ID: 16405939
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
[TBL] [Abstract][Full Text] [Related]
11. Biomonitoring of smoke constituents: exposure to 4-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in nonsmokers and smokers.
Schorp MK; Leyden DE
Inhal Toxicol; 2010 Aug; 22(9):725-37. PubMed ID: 20433335
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard.
Beland FA; Doerge DR; Churchwell MI; Poirier MC; Schoket B; Marques MM
Chem Res Toxicol; 1999 Jan; 12(1):68-77. PubMed ID: 9894020
[TBL] [Abstract][Full Text] [Related]
13. Detection and characterization of carcinogen-DNA adducts in exfoliated urothelial cells from 4-aminobiphenyl-treated dogs by 32P-postlabelling and subsequent thin-layer and high-pressure liquid chromatography.
Talaska G; Dooley KL; Kadlubar FF
Carcinogenesis; 1990 Apr; 11(4):639-46. PubMed ID: 2323002
[TBL] [Abstract][Full Text] [Related]
14. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers.
Bryant MS; Skipper PL; Tannenbaum SR; Maclure M
Cancer Res; 1987 Jan; 47(2):602-8. PubMed ID: 3791245
[TBL] [Abstract][Full Text] [Related]
15. In vivo dosimetry of 4-aminobiphenyl in rats via a cysteine adduct in hemoglobin.
Green LC; Skipper PL; Turesky RJ; Bryant MS; Tannenbaum SR
Cancer Res; 1984 Oct; 44(10):4254-9. PubMed ID: 6467185
[TBL] [Abstract][Full Text] [Related]
16. Acetyl transferase-mediated metabolic activation of N-hydroxy-4-aminobiphenyl by human uroepithelial cells.
Frederickson SM; Hatcher JF; Reznikoff CA; Swaminathan S
Carcinogenesis; 1992 Jun; 13(6):955-61. PubMed ID: 1600616
[TBL] [Abstract][Full Text] [Related]
17. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.
Culp SJ; Roberts DW; Talaska G; Lang NP; Fu PP; Lay JO; Teitel CH; Snawder JE; Von Tungeln LS; Kadlubar FF
Mutat Res; 1997 Aug; 378(1-2):97-112. PubMed ID: 9288889
[TBL] [Abstract][Full Text] [Related]
18. Modeling human interindividual variability in metabolism and risk: the example of 4-aminobiphenyl.
Bois FY; Krowech G; Zeise L
Risk Anal; 1995 Apr; 15(2):205-13. PubMed ID: 7597257
[TBL] [Abstract][Full Text] [Related]
19. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder.
Badawi AF; Hirvonen A; Bell DA; Lang NP; Kadlubar FF
Cancer Res; 1995 Nov; 55(22):5230-7. PubMed ID: 7585581
[TBL] [Abstract][Full Text] [Related]
20. The metabolism of 4-aminobiphenyl in rat. II. Reaction of N-hydroxy-4-aminobiphenyl with rat blood in vitro.
Heilmair R; Karreth S; Lenk W
Xenobiotica; 1991 Jun; 21(6):805-15. PubMed ID: 1949910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]